The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer
- PMID: 25101600
- DOI: 10.1097/DCR.0000000000000193
The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer
Abstract
Background: The prognostic role of surgical resection of primary tumors is not well established in patients with asymptomatic unresectable stage IV colorectal cancer.
Objective: The aims of this study were to reveal the prognostic role of surgical resection of primary tumors and to define prognostic factors affecting long-term oncological outcomes in patients with asymptomatic unresectable synchronous metastases.
Design: This study was a retrospective analysis of prospectively collected data.
Patients: Between 2000 and 2008, a total of 416 patients with asymptomatic unresectable stage IV colorectal cancer were analyzed with propensity score matching.
Main outcome measures: Prematching baseline characteristics were compared by bivariate analysis, and 113 pairs were selected after 1:1 matching with propensity scores estimated from logistic regression. The primary end point was overall survival.
Results: Among 416 patients, 218 (52.4%) underwent palliative resection of the primary tumor. Before propensity score matching, palliative resection resulted in a better survival rate than nonresection in univariate analysis (p < 0.001), but not in multivariate analysis (p = 0.08). After matching, the 5-year overall survival rate was significantly lower for patients with peritoneal metastasis and clinical M1b stage tumors in univariate analysis (p = 0.004 and p = 0.02). However, neither peritoneal metastasis nor clinical M1b stage showed any prognostic significance in multivariate analysis. The overall 5-year survival rate of the postmatching group was 4.9% and 3.5% in the palliative resection and nonresection groups. Consequently, palliative resection was not associated with a significant increase in survival compared with nonresection (p = 0.27). A subgroup analysis performed according to the site of metastasis also did not show any significant survival benefit of palliative resection after matching.
Limitations: Selection bias and potential confounders were limitations of this study.
Conclusions: Resection of the primary tumor in patients with asymptomatic unresectable stage IV colorectal cancer was not associated with an improvement in overall survival after propensity score matching.
Similar articles
-
Primary tumor location as a predictor of the benefit of palliative resection for colorectal cancer with unresectable metastasis.World J Surg Oncol. 2017 Jul 27;15(1):138. doi: 10.1186/s12957-017-1198-0. World J Surg Oncol. 2017. PMID: 28750680 Free PMC article.
-
Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database.Int J Clin Oncol. 2015 Oct;20(5):922-7. doi: 10.1007/s10147-015-0815-6. Epub 2015 Mar 12. Int J Clin Oncol. 2015. PMID: 25762168
-
Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis.J Surg Oncol. 2014 Mar;109(3):239-44. doi: 10.1002/jso.23480. Epub 2013 Oct 25. J Surg Oncol. 2014. PMID: 24165972
-
Surgery of the primary in stage IV colorectal cancer with unresectable metastases.Eur J Cancer. 2011 Sep;47 Suppl 3:S61-6. doi: 10.1016/S0959-8049(11)70148-4. Eur J Cancer. 2011. PMID: 21944031 Review.
-
Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.Dis Colon Rectum. 2013 Dec;56(12):1373-80. doi: 10.1097/DCR.0b013e3182a62d9d. Dis Colon Rectum. 2013. PMID: 24201391 Review.
Cited by
-
Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer.Cancers (Basel). 2023 Oct 19;15(20):5057. doi: 10.3390/cancers15205057. Cancers (Basel). 2023. PMID: 37894424 Free PMC article.
-
The Impact of Primary Tumor Resection on Survival in Asymptomatic Colorectal Cancer Patients With Unresectable Metastases.Ann Coloproctol. 2021 Apr;37(2):94-100. doi: 10.3393/ac.2020.09.15.1. Epub 2021 Apr 30. Ann Coloproctol. 2021. PMID: 33979907 Free PMC article.
-
The role of upfront primary tumor resection in asymptomatic patients with unresectable stage IV colorectal cancer: A systematic review and meta-analysis.Front Surg. 2023 Jan 6;9:1047373. doi: 10.3389/fsurg.2022.1047373. eCollection 2022. Front Surg. 2023. PMID: 36684350 Free PMC article. Review.
-
Palliative primary tumor resection may not offer survival benefits for patients with unresectable metastatic colorectal neuroendocrine neoplasms, one multicenter retrospective cohort study.BMC Surg. 2024 Mar 12;24(1):85. doi: 10.1186/s12893-024-02380-9. BMC Surg. 2024. PMID: 38475759 Free PMC article.
-
Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials.Int J Cancer. 2016 Nov 1;139(9):1927-9. doi: 10.1002/ijc.30244. Epub 2016 Jul 12. Int J Cancer. 2016. PMID: 27400774 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical